99mTc-sucralfate scintigraphy in inflammatory bowel disease.
Technetium-99m-labeled albumin-sucralfate was orally administered to 11 patients (Crohn's disease, 8; ulcerative colitis, 3) and 3 healthy volunteers. Serial scintigraphy was performed, and scintigraphic interpretations were compared with radiographic and endoscopic findings in an open study. We were not able in any patient to relate the scintigraphic findings to the localizations of inflammatory bowel disease, nor could we distinguish the scans in the patients from the scans of the healthy volunteers. We conclude that 99mTc-albumin-sucralfate scintigraphy is of no value in the detection of inflammatory bowel disease.
Mortensen
P B
PB
Dept. of Medical Gastroenterology, Aalborg Hospital, Denmark.
Lech
Y
Y
Møller-Petersen
J
J
Vilien
M
M
Fallingborg
J
J
Ekelund
S
S
D000328:Adult; D000368:Aged; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000000981:diagnostic imaging*; D003424:Crohn Disease / Q000175:diagnosis / Q000000981:diagnostic imaging*; D005069:Evaluation Studies as Topic; D006801:Humans; D008875:Middle Aged; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D013392:Sucralfate
D015609:Organotechnetium Compounds; C038248:technetium Tc 99m sucralfate; D013392:Sucralfate